ANDA 220380, held by Amneal. Ketamine Hydrochloride.
As of Nov 16, 2026, ANDA 220380 (Ketamine Hydrochloride), held by Amneal, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 31, 2025 | Original application | Tentative approval |
| Ketamine HydrochlorideEQ 50MG BASE/5ML (EQ 10MG BASE/ML) · solution;intramuscular, intravenous | Ketamine Hydrochloride | Rx |
| Ketamine HydrochlorideEQ 50MG BASE/ML (EQ 50MG BASE/ML) · solution;intramuscular, intravenous | Ketamine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters